FROM CLINICAL TRIALS THROUGH POST-APPROVAL

Patient Safety & Pharmacovigilance

Effective and Efficient End-to-End Patient Safety Solutions

With Fortrea’s integrated, global safety team, you will benefit from end-to-end safety solutions that span the entire product life cycle of drugs, medical devices, combination products and vaccines from early clinical phases through post-approval. Automation systems help drive increased operational efficiencies across the continuum, while our extensive experience and proven best practices provide quality and regulatory compliance you can trust.

The Fortrea Patient Safety and Pharmacovigilance (PV) Advantage
  • Full breadth of safety services from trials through post-approval tailored to specific client needs
  • 99.5% regulatory compliance
  • 50+ PV-specific audits and regulatory inspections with no critical findings
  • Integrated global safety team of 2,600+ members across 19 delivery centers
  • Industry standard safety systems and proprietary automation for increased efficiency
  • Over 32 years of safety experience and best practices to deliver quality and regulatory compliance
Over 1.1 million cases were processed in 2022 alone with zero critical findings and 99.6% regulatory reporting compliance, achieved through process efficiencies and Fortrea’s innovative automation technologies.

Flexible Patient Safety Solutions (PSS) include:

  • Medical Contact Center
  • Case Processing
  • Medical Review
  • Aggregate Reporting
  • Safety Surveillance
  • QPPV support

 

Fortrea develops strategic partnerships, approaches and practices to gain efficiencies and increase the value of your operations. Partner with Fortrea for a unique experience, where you control your journey from start to finish. Regardless of where you are and how far you aspire to go, choose the options that make the most of your endeavor.

Contact us to get started today.

Stay up to date:
Subscribe for Fortrea news & announcements.